Schedule 13G

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JIgQ37QCSA+b4chS/LMoVBs2Iy044z5wQIoFUVROJsiu/bYPCV2i5RxgzQH2E95K U5wniwf73QIb0xlcFe82/w== 0001193125-08-010942.txt : 20080124 0001193125-08-010942.hdr.sgml : 20080124 20080124061157 ACCESSION NUMBER: 0001193125-08-010942 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080124 DATE AS OF CHANGE: 20080124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WuXi PharmaTech (Cayman) Inc. CENTRAL INDEX KEY: 0001403132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83350 FILM NUMBER: 08546074 BUSINESS ADDRESS: STREET 1: 288 FUTE ZHONG ROAD STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 BUSINESS PHONE: 86-21-5046-1111 MAIL ADDRESS: STREET 1: 288 FUTE ZHONG ROAD STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Li Ge CENTRAL INDEX KEY: 0001424321 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: 86-21-5046 3309 MAIL ADDRESS: STREET 1: 288 FUTE ZHONGLU STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

WuXi PharmaTech (Cayman) Inc.

(Name of Issuer)

Ordinary Shares**

American Depositary Shares

(Title of Class of Securities)

929352102***

(CUSIP Number)

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

**	Not for trading, but only in connection with the registration of American Depositary Shares each representing 8 ordinary shares.

***	This CUSIP applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).


1		NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ge Li
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION United States of America


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5 SOLE VOTING POWER 35,320,950¹
		6 SHARED VOTING POWER 0
		7 SOLE DISPOSITIVE POWER 35,320,950²
		8 SHARED DISPOSITIVE POWER 0


9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 35,320,950
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.97%
12	TYPE OF REPORTING PERSON^* IN

Includes (i) 1,296,400 shares held directly by Dr. Ge Li; (ii) 19,499,550 ordinary shares held by J.P. Morgan Trust Company of Delaware, as Trustee of the Ning Zhao 2006 Grantor Retained Annuity Trust, for which Dr. Li is the Investment Advisor and exercises sole dispositive and voting power; and (iii) 14,525,000 ordinary shares issuable upon exercise of options held by Dr. Li.

²	See footnote 1.


Item 1(a)		Name of Issuer: WuXi Pharmatech (Cayman) Inc. (“Issuer”)

Item 1(b)		Address of Issuer’s Principal Executive Offices: 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China

Item 2(a)		Name of Person Filing:

		Ge Li

Item 2(b)		Address of Principal Business Office or, If None, Residence; Citizenship

		Ge Li
		c/o WuXi Pharmatech (Cayman) Inc.
		288 Fute Zhong Road
		Waigaoqiao Free Trade Zone
		Shanghai 200131
		People’s Republic of China

Item 2(c)		Citizenship

		United States of America

Item 2(d)		Title of Class of Securities: Ordinary shares, par value US$0.02

		American Depositary Shares

Item 2(e)		CUSIP Number: 929352102

Item 3.		Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c): Not applicable.


Item 4.		Ownership

		(a) Amount Beneficially Owned:

Reporting Person

Amount
beneficially

owned:

Percent

of class:

Sole power

to vote or

direct

the vote:

Shared

power to

vote or to

direct

the vote:

Sole power to
dispose or to

direct the

disposition of:

Shared power
to dispose or to
direct the

disposition of:

Ge Li

35,320,950

ordinary

6.97%

35,320,950

ordinary

35,320,950

ordinary


Item 5.		Ownership of Five Percent or Less of a Class Not applicable.

Item 6.		Ownership of More Than Five Percent on Behalf of Another Person Not applicable.

Item 7.		Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

		Not applicable.

Item 8.		Identification and Classification of Members of the Group

		Not applicable.

Item 9.		Notice of Dissolution of Group

		Not applicable.

Item 10.		Certifications

		Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 24, 2008

Ge Li

/s/ Ge Li

-----END PRIVACY-ENHANCED MESSAGE-----